Immunotherapy is about priming the immune system to identify and attack cancer cells and is recognised as the future of cancer treatment. Innovita Life is at the forefront of the fight against cancer which can also be given with more traditional treatments of cancer such as chemotherapy, radiotherapy and surgery.

What is cell immunotherapy?

Cell immunotherapy harnesses the body’s immune system to identify and destroy cancer cells. Immunotherapy can be used to treat most types of cancer including, pancreatic, lung, colon, breast, and melanomas. In fact all solid tumours and metastases  For more information about immunotherapy cancer treatment click here.

How does cell immunotherapy work?

Cancer thrives when your immune system is not working correctly. Cancer hides which makes it difficult for the immune system to recognise and destroy malignant  cells. Cell immunotherapy is at the cutting edge of today’s cancer treatment that works by using your body’s own immune system (or a replacement immune system) to identify and fight cancer cells.  Cell immunotherapy uses your blood to cultivate Dendritic Cells (as an example of one approach) which are then primed with antigens to identify and destroy cancer cells before being reintroduced via a vaccine.  It’s a natural, minimally invasive, pain free process with none of the unpleasant side-effects associated with more traditional cancer treatments like chemotherapy.

How do I know if I am a suitable candidate for cell immunotherapy?

Cell immunotherapy can be used as alternative cancer treatment for many forms of cancer. It can be beneficial for patients with the following cancers, even in advanced stages: bladder cancer, cervical cancer, lung and liver cancer, prostate cancer, oral cancer, ovarian cancer, gastric cancer, colon cancer, renal cancer, skin cancer, head and neck cancers. It is important to get personalised advice based on your specific situation. Request a confidential call back from Innovita Life to discuss your suitability or get a second opinion here.

Can cell immunotherapy be combined with other treatments?

Yes, cell immunotherapy can be administered prior to or in conjunction with more traditional cancer treatment paths, such as chemotherapy, radiotherapy and surgery. Studies have shown that cancer survival rates can be increased when cell immunotherapy has been administered alongside chemotherapy or other traditional cancer treatments.

Why is immunotherapy considered to be the future of cancer treatment?

Immunotherapy moves the field of cancer care an unprecedented step forward toward precision cancer therapies. Unlike traditional treatments of cancer, such as radiotherapy and chemotherapy, immunotherapy precisely targets and destroys the corrupted cancer cells, without harming healthy cells. This makes it possible to deliver more targeted cancer treatment without the side effects associated with radiotherapy and chemotherapy.  

Do I need a referral from my doctor to undergo cell immunotherapy?

The medical profession is aware of dendritic cell therapy but it is not yet a mainstream treatment for cancer. It is not necessary for your doctor or clinic to refer you for cell immunotherapy treatment. However, it is necessary for your doctor to provide your full medical history and status.  Full details about how cell immunotherapy treatment works, results, side effects and eligibility will be provided during your consultation with Innovita Life’s cell immunotherapy experts.

How long does a typical cell immunotherapy treatment last?

Once the cell immunotherapy vaccine has been administered it will remain active for up to 2 years and more. However, it is important to remember that every patient is different and reacts differently to both traditional and cell immunotherapy cancer treatments. Therefore, how long after the treatment you will start to see the results will depend upon your individual immune system. There are other immunotherapy approaches that act immediately and are prescribed for patients that need immediate assistance.

Where can I get Innovita Life’s cell immunotherapy treatment?

Innovita Life has qualified medical staff operating in several locations, which means we may be able to arrange some of  your treatment to be carried out in the most convenient location for you.

What is the cost of cell immunotherapy?

Every patient’s medical health and medical situation is different therefore it is not possible to provide a one-size-fits-all cost for this type of treatment for cancer. The cost of the treatment will depend upon your specific cancer and medical status. Get in touch to request a free confidential consultation.

What are the survival rates for cell immunotherapy cancer treatment?

Every patient is different. However, according to oncologist, Najwa Buhlaiga, compared to more traditional forms of treatment for cancer, such as chemotherapy, radiotherapy, and surgery, cell immunotherapy has results in significant improvements in patient survival rates and quality of life. There are many clinical studies investigating the efficiency of cell immunotherapy, you can read a selection of clinical papers on our website here. And you can review the survival rates of some of the groups we have experience with and the improved survival with cell immunotherapy when a response is achieved

Also, here are the findings from a recent study (full details can be downloaded from our website). This particular research comprised patients with terminal stage metastatic cutaneous melanomas, ovarian cancer, glioblastoma multiform. Some patients were part of the control group which received only standard treatment for cancer and other were treated with Dendritic cells (cell immunotherapy using patients’ immune system). Patients in all groups were of the same age and fulfilled the same clinical parameters. Here are some of the results illustrating the improved long-term overall survival rates for the group treated with Dendritic cells.


6 months: 100% in Dendritic cell group vs 41.6% in control group

12 months: 58.3% in Dendritic cell group vs 0% in control group

Ovarian cancer

12 months: 100% in Dendritic cell group vs 94.4% in control group

24 months: 100% in Dendritic cell group vs 61.1% in control group

36 months: 94.4% in Dendritic cell group vs 5.5% in control group

Breast cancer

36 months: 100% in Dendritic cell group vs 83% in control group

60 months: 90% in Dendritic cell group vs 58% in control group

120 months: 86% in Dendritic cell group vs 46% in control group


12 months: 100% in the standard treatment + Dendritic cell group vs 80% in the control group.

24 months: 30% in the standard treatment + Dendritic cell group vs 0% in the control group.

36 months: 10% in the standard treatment + Dendritic cell group vs 0% in the control group.